Ladenburg Thalmann Financial Services’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1K Sell
43
-155
-78% -$3.71K ﹤0.01% 5263
2019
Q3
$3K Sell
198
-269
-58% -$5.24K ﹤0.01% 4902
2019
Q2
$11K Buy
467
+322
+222% +$10.1K ﹤0.01% 4407
2019
Q1
$5K Buy
145
+28
+24% +$1.15K ﹤0.01% 4694
2018
Q4
$4K Buy
117
+67
+134% +$5.65K ﹤0.01% 4710
2018
Q3
$7K Buy
50
+20
+67% +$2.96K ﹤0.01% 4475
2018
Q2
$7K Hold
30
﹤0.01% 4464
2018
Q1
$7K Buy
30
+13
+76% +$3.66K ﹤0.01% 4464
2017
Q4
$5K Buy
+17
New +$6.49K ﹤0.01% 4542

Other funds holding VYNT

Ladenburg Thalmann Financial Services's VYNT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Vyant Bio, Inc. Common Stock (VYNT) stake by 78% in Q4 2019, selling an estimated $3.71K and leaving 43 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5263.

Ladenburg Thalmann Financial Services first reported a position in VYNT in Q4 2017 and has held it in 9 quarters since. The position peaked at $11K in Q2 2019. 18 funds tracked by Wall St. Rank hold VYNT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 43 shares of Vyant Bio, Inc. Common Stock worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 155 Vyant Bio, Inc. Common Stock shares in Q4 2019, an estimated $3.71K.
  • Vyant Bio, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5263 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Vyant Bio, Inc. Common Stock in Q4 2017 and has held it in 9 quarters since.
  • Ladenburg Thalmann Financial Services's Vyant Bio, Inc. Common Stock position peaked at $11K in Q2 2019.
  • 18 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.